findmyKOL

Joseph Eron, MD

Enriched profile

Chief, Division of Infectious Diseases; Herman and Louise Smith Distinguished Professor of Medicine · University of North Carolina at Chapel Hill

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Chapel Hill, NC · Southeast · United StatesSpecialtyInfectious DiseaseFocusHIV
Active KOLEmergingfindmyKOL type: EliteLatest publication2025Online presenceverified 2026Payments2021–2025NIH funding1995–2026Why? →

Joseph Eron is Chief, Division of Infectious Diseases; Herman and Louise Smith Distinguished Professor of Medicine at University of North Carolina at Chapel Hill. ClinicalTrials.gov lists 6 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Joseph J. Eron, Jr., MD, is Chief, Division of Infectious Diseases at University of North Carolina at Chapel Hill, School of Medicine. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 8 companies, 9 NIH-funded awards (1995–2026).

  • Top research focus: HIV
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
HIV6 trialsHIV Infections5 trials

Research focus

OpenAlex concept fingerprint
HIV

Drugs & molecules

across trials, industry payments and publications
Biktarvygeneric · Bictegravir / emtricitabine / tenofovir alafenamideClinical trials—Industry payments2Publications—Dovatogeneric · Dolutegravir / lamivudineClinical trials—Industry payments2Publications—CabenuvaClinical trials—Industry payments1Publications—EnsitrelvirClinical trials—Industry payments1Publications—Fetrojageneric · CefiderocolClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Merck Sharp & Dohme LLCClinical trials—Industry payments39Gilead Sciences, Inc.Clinical trials—Industry payments31ViiV Healthcare CompanyClinical trials—Industry payments13National Institute of Allergy and Infectious Diseases (NIAID)Clinical trials5Industry payments—Janssen Scientific Affairs, LLCClinical trials—Industry payments4GlaxoSmithKline, LLC.Clinical trials—Industry payments3Shionogi IncClinical trials—Industry payments2Abbvie Inc.Clinical trials—Industry payments1Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsClinical trials1Industry payments—Merck Sharp & Dohme CorporationClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
25h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
8companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
9NIH grants · 1995–2026

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    51.3%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor17.5%
    Tivicay57%Dovato15%Juluca11%Isentress10%Cabenuva8%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor10.9%
    Descovy100%
    Part D≥12 patients

    + 7 more classes in this area

  • Nervous system

    26.4%
    Opioid Agonist11.2%
    Oxycodone-Acetaminophen47%Oxycodone Hcl42%Morphine Sulfate Er11%
    Part D<11 patients
    Benzodiazepine5.4%
    Alprazolam68%Clonazepam32%
    Part D<11 patients

    + 5 more classes in this area

  • Cardiovascular

    12.3%
    Statin7.3%
    Atorvastatin Calcium51%Rosuvastatin Calcium49%
    Part D<11 patients
    Thiazide diuretic3%
    Hydrochlorothiazide100%
    Part D<11 patients

    + 1 more class in this area

All 7 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)67.9% facility · 32.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

9 NIH research awards on record, funded 1995–2026 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/joseph-eron-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Joseph-Eron-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/joseph_eron

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • LinkedIn

    linkedin.com/in/joseph-eron-474ba6a

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

Mentions by others

where others cite or feature them
  • LinkedIn

    linkedin.com/posts/unc-department-of-medicine_a-phase-2-study-led-by-dr-joe-eron-chief-activity-7424125776381321216-qSUZ

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Harvard Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Residency

    Internal Medicine, Massachusetts General Hospital, Harvard Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Fellowship

    Infectious Diseases, Massachusetts General Hospital, Harvard Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Undergraduate degree

    Harpur College

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗

Editorial & leadership roles

journal and society appointments
  • Member

    AIDS Clinical Trials Group (since 1993); former Chair, Optimization of ART Committee and Cure/HIV Reservoirs Transformative Science Group

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Vice Chair (co-Principal Investigator)

    AIDS Clinical Trials Group (ACTG) / Advancing Clinical Therapeutics Globally

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Leader

    ACTG Scientific Agenda Steering Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Principal Investigator

    HIV/AIDS Clinical Research Unit and UNC Clinical Trials Unit, UNC-Chapel Hill

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iasusa.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Adjunct Professor of Epidemiology

    UNC Gillings School of Global Public Health

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sph.unc.edu ↗
  • Director

    Clinical Core, UNC Center for AIDS Research (CFAR)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Faculty

    UNC Institute for Global Health and Infectious Diseases

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globalhealth.unc.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.